Woodline Partners’s 89bio ETNB Stock Holding History

Woodline Partners’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-172,779	Closed	-$2.54M	–	1053
2025 Q3	$2.54M	Sell	172,779 -1,049,882	-86%	-$10.7M	0.01%	695
2025 Q2	$12M	Buy	1,222,661 +521,907	+74%	+$4.32M	0.06%	383
2025 Q1	$5.09M	Buy	700,754 +305,928	+77%	+$2.67M	0.03%	504
2024 Q4	$3.09M	Buy	394,826 +341,479	+640%	+$2.81M	0.02%	579
2024 Q3	$395K	Buy	+53,347	New	+$449K	﹤0.01%	549

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Woodline Partners's ETNB Position: Q4 2025 in Review

Woodline Partners sold out of 89bio (ETNB) in Q4 2025, closing a stake of 172,779 shares — an estimated $2.54M sold.

Woodline Partners first reported a position in ETNB in Q3 2024 and held it in 5 quarters. The position peaked at $12M in Q2 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Woodline Partners reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Woodline Partners sold 172,779 89bio shares in Q4 2025, an estimated $2.54M.
Woodline Partners first reported a position in 89bio in Q3 2024 and held it in 5 quarters.
Woodline Partners's 89bio position peaked at $12M in Q2 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.